Title
A case-control study of oxidized low density lipoproteins and preeclampsia risk
Date Issued
01 October 2005
Access level
metadata only access
Resource Type
journal article
Author(s)
Abstract
Diffuse vascular endothelial dysfunction, secondary to oxidative stress, is an important pathological feature of preeclampsia. Oxidative conversion of low density lipoproteins (LDL) to oxidized-LDL (Ox-LDL) is considered an important step in transforming macrophages into lipid-laden foam cells destined to develop into early atherosclerotic-like lesions. In our study of 95 women with preeclampsia and 100 controls, we evaluated the association between maternal plasma Ox-LDL concentrations and preeclampsia risk. Ox-LDL concentrations were measured using a solid phase two-site enzyme immunoassay. Plasma lipids were measured using standard enzymatic procedures. We used logistic regression to estimate odds ratios (OR) and 95% confidence intervals (CI) adjusted for confounders. Plasma Ox-LDL concentrations were positively correlated with cholesterol, triglyceride (TG), and LDL concentrations in cases and controls, (Spearman's r ranging from 0.39-0.48, p-values all < 0.01). There was no evidence of an increased risk of preeclampsia across increasing quartiles of Ox-LDL. The ORs for successive quartiles, with the lowest as the reference group, were as follows: 1.0, 1.1, 0.6, and 1.2. Women with extremely high concentrations of Ox-LDL (≥ 73 U/L, the upper decile), as compared with those with lower values (< 73 U/L) had a 2.7-fold increased risk of preeclampsia (95% CI 1.0-6.8). Women with high Ox-LDL and high TG concentrations (≥ 284 mg/dl), as compared with those without these two factors, had a 9.6-fold increased preeclampsia risk (95% CI 2.0-45.6). Elevated Ox-LDL, particularly in conjunction with elevated TG, appears to be a risk factor of preeclampsia. © 2005 Taylor & Francis.
Start page
193
End page
199
Volume
21
Issue
4
Language
English
OCDE Knowledge area
Pediatría
Obstetricia, Ginecología
Subjects
Scopus EID
2-s2.0-28844481894
PubMed ID
Source
Gynecological Endocrinology
ISSN of the container
09513590
Sponsor(s)
This research was supported in part by awards from the National Institutes of Health (T37-TW00049; RO3-TW01159; and R01-32562). The authors wish to thank Elena Sanchez for her expert technical assistance.
Sources of information:
Directorio de Producción Científica
Scopus